alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2


                                 CERTIFICATIONS

I, Timothy L. Felter, certify that:

(1) I have reviewed this quarterly report on Form 10-QSB of First Ipswich
Bancorp;

(2) Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the company as of,
and for, the periods presented in this report;

(4) The company's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and we have:

     a) Designed such disclosure controls and procedures, or caused such
     disclosure controls and procedures to be designed under our supervision, to
     ensure that material information relating to the company, including its
     consolidated subsidiaries, is made known to us by others within those
     entities, particularly during the period in which this report is being
     prepared;

     b) Evaluated the effectiveness of the company's disclosure controls and
     procedures and presented in this quarterly report our conclusions about the
     effectiveness of the disclosure controls and procedures, as of the end of
     the period covered by this report based on such evaluation; and

     c) Disclosed in this report any change in the company's internal control
     over financial reporting that occurred during the company's most recent
     fiscal quarter that has materially affected, or is reasonably likely to
     materially affect, the company's internal control over financial reporting;
     and

(5) The company's other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
company's auditors and the audit committee of the company's board of directors
(or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or
     operation of internal control over financial reporting which are reasonably
     likely to adversely affect the company's ability to record, process,
     summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other
     employees who have a significant role in the company's internal control
     over financial reporting.


/s/ Timothy L. Felter
----------------------------
Timothy L. Felter
Chief Financial Officer

November 14, 2006
Exhibit 12.1
 GENERAL CABLE CORPORATION AND SUBSIDIARIES
 Computation of Ratio of Earnings to Fixed Charges
(in millions)
 Three FiscalMonthsEndedApril 2,
    
    
    Year ended December 31,2010
    
    
    2009
    
    
    2008
    
    
    2007
    
    
    2006
    
    
    2005EARNINGS AS DEFINEDEarnings from operations before income taxes and
before
adjustments for minority interests in consolidated
subsidiaries and after eliminating undistributed earnings
of equity method investees
    
    $
    57.3
    
    
    $
    96.3
    
    
    $
    280.4
    
    
    $
    298.5
    
    
    $
    368.4
    
    
    $
    115.5Preferred stock dividend (pre-tax equivalent)
    
    
    (0.1
    )
    
    
    (0.3
    )
    
    
    (0.3
    )
    
    
    (0.5
    )
    
    
    (0.5
    )
    
    
    (33.8
    )Fixed charges
    
    
    20.6
    
    
    
    92.7
    
    
    
    109.2
    
    
    
    71.3
    
    
    
    44.4
    
    
    
    76.7TOTAL EARNINGS, AS DEFINED
    
    $
    77.8
    
    
    $
    188.7
    
    
    $
    389.3
    
    
    $
    369.3
    
    
    $
    412.3
    
    
    $
    158.4FIXED CHARGES, AS DEFINEDInterest expense
    
    $
    18.2
    
    
    $
    82.1
    
    
    $
    98.4
    
    
    $
    63.6
    
    
    $
    38.1
    
    
    $
    36.5Amortization of capitalized expenses related to debt
    
    
    0.8
    
    
    
    4.5
    
    
    
    5.7
    
    
    
    3.6
    
    
    
    3.0
    
    
    
    3.4Preferred stock dividend (pre-tax equivalent)
    
    
    0.1
    
    
    
    0.3
    
    
    
    0.3
    
    
    
    0.5
    
    
    
    0.5
    
    
    
    33.8Interest component of rent expense
    
    
    1.5
    
    
    
    5.8
    
    
    
    4.8
    
    
    
    3.6
    
    
    
    2.8
    
    
    
    3.0TOTAL FIXED CHARGES, AS DEFINED
    
    $
    20.6
    
    
    $
    92.7
    
    
    $
    109.2
    
    
    $
    71.3
    
    
    $
    44.4
    
    
    $
    76.7RATIO OF EARNINGS TO FIXED CHARGES
    
    
    3.8
    
    
    
    2.0
    
    
    
    3.6
    
    
    
    5.2
    
    
    
    9.3
    
    
    
    2.1
No. 976.

#### Stein *v.*United States.

April 29, 1946.

*Isaac Pacht, Clore Warne*and *Louis M. Brown*for petitioner.

*Solicitor Gen*
      *835
      *eral McGrath, Robert S. Erdahl*and *Andrew F. Oehmann*for the United States.

*834Petition for writ of certiorari to the Circuit Court of Appeals for the Ninth Circuit denied.
Exhibit 21

List
of Principal Subsidiaries of Inamed Corp.

|Subsidiary                                       |  | Country         |  | State     
|------------------------------------------------ |  | --------------- |  | ----------
|AEI, Inc.                                        |  | US              |  | Delaware  
|Bioenterics Corporation                          |  | US              |  | California
|Collagen KK                                      |  | Japan           |  |           
|Collagen Aesthetics (UK) Limited                 |  | UK              |  |           
|Collagen Aesthetics Australia Pty. Ltd.          |  | Australia       |  |           
|Collagen Aesthetics GmbH                         |  | Germany         |  |           
|Collagen Aesthetics Iberica SA                   |  | Spain           |  |           
|Collagen Aesthetics SRL                          |  | Italy           |  |           
|Collagen Aesthetics Inc.                         |  | US              |  | California
|Collagen Vertrieb Biomedizinischer Produkte GmbH |  | Austria         |  |           
|Inamed Canada Inc.                               |  | Canada          |  |           
|Inamed International Corporation                 |  | US              |  | Delaware  
|Inamed Medical Products Corporation              |  | US              |  | California
|Innermedical Limited                             |  | UK              |  |           
|McGhan Deutschland GmbH & Co. KG                 |  | Germany         |  |           
|McGhan Limited                                   |  | Ireland         |  |           
|McGhan Medical BV                                |  | The Netherlands |  |           
|McGhan Medical GmbH                              |  | Germany         |  |           
|McGhan Medical SA                                |  | Spain           |  |           
|McGhan Medical SARL                              |  | France          |  |           
|McGhan Medical SRL.                              |  | Italy           |  |           
|McGhan Médico SA                                 |  | Costa Rica      |  |           

---

QuickLinks
Exhibit 32.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of First Ipswich Bancorp (the
"Company") on Form 10-QSB for the quarter ended March 31, 2006 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy
L. Felter, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

      (1)   The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      (2)   The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.

      This certification is provided solely pursuant to 18 U.S.C. Section 1350
and Item 601(b)(32) of Regulation S-B ("Item 601(b)(32)") promulgated under the
Securities Act of 1933 (the "Securities Act") and the Securities Exchange Act of
1934 (the "Exchange Act"). In accordance with clause (ii) of Item 601(b)(32),
this certification (A) shall not be deemed "filed" for purposes of Section 18 of
the Exchange Act, or otherwise subject to the liability of that section, and (B)
shall not be deemed to be incorporated by reference into any filing under the
Securities Act or the Exchange Act, except to the extent that the Company
specifically incorporates it by reference.


/s/ Timothy L. Felter
--------------------------------
Timothy L. Felter
Chief Financial Officer

May 12, 2006
##### 



EXHIBIT 32.2

Certification Pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350)

The undersigned, as the Chief Executive Officer of Zale Corporation,
certifies, to the best of his knowledge, that the Annual Report on Form 10-K
for the fiscal year end July 31, 2003, which accompanies this certification
fully complies with the requirements of Section 13(a) of the Securities
Exchange Act of 1934 and the information contained in the periodic report
fairly presents, in all material respects, the financial condition and results
of operations of Zale Corporation at the dates and for the periods indicated.
The foregoing certification is made pursuant to § 906 of the Sarbanes-Oxley Act
of 2002 (18 U.S.C. § 1350) and shall not be relied upon for any other purpose.

This 9th day of October, 2003.

| |     |                                                
| | --- | -----------------------------------------------
| | By: | /s/ Mark R. Lenz                               
| |     |                                                
| |     |                                                
| |     | Mark R. Lenz                                   
| |     | Group Senior Vice President and                
| |     | Chief Financial Officer                        
| |     | (principal financial officer of the registrant)
C OURT OF A PPEALS FOR THE

F IRST D ISTRICT OF T EXAS AT H OUSTON

O RDER

Appellate case name: C.B. v. Department of Family and Protective Services

Appellate case number: 01

- 16

- 00989

- CV

Trial court case number: 2015

- 26726

Trial court: 309th District Court of Harris County

This is an accelerated appeal from an order terminating appellant’s parental rights. On January 18, 2017, court reporter Walter Johnson filed a notice that he was unable to produce a record for August 16, 2017 because he found nothing on disk or paper for that day. Johnson has

informed our court clerk that he believes , after reviewing the docket sheet and talking to Assistant County Attorney Francie Aguirre, that no testimony was taken that day and the only proceeding

was to declare the f

ather indigent.

Appellant’s appointed counsel states that the missing record raises no arguable issue because the existing record supports the trial court’s judgment.

Under Rule 34.6(f), an appellant is entitled to a new trial if the reporter’s record was timely requested, a significant portion of the court reporter’s notes or records have been lost or destroyed, the lost or destroyed portion is necessary to resolution of the appeal, and the missing portion cannot be replaced either by agreement or with a copy the trial court determines is an accurate duplicate of any original exhibit. See T EX

. R. A PP

. P. 34.6(f).

Accordingly, we abate the appeal and remand the case to the trial court for a n evidentiary hearing to determine , after hearing testimony from W alter Johnson and Francie Aguirre, the following : (1) whether a significant portion of the court reporter’s notes and record were lost or destroyed; (2) whether the lost or destroyed portion of the reporter’s record is necessary to the resolution of the ap peal; and (3) if the lost portion of the reporter’s record can be replaced by agreement or by the trial court. We order the court to prepare a record, in the form of a reporter’s record, of the hearing. The judge shall make findings of fact and conclusions of law, and shall order the trial clerk to forward to this court a supplemental clerk’s record containing the findings and conclusions. The hearing record and supplemental clerk’s record shall be filed with the clerk

of this court within 15 days of the date of this order.

The appeal is abated, treated as a closed case, and removed from this court’s active docket. The appeal will be reinstated on this court’s active docket when the trial court’s findings andrecommendations are filed in this court. The court will also consider an appropriate motion to

reinstate the appeal filed by either party, or the court may reinstate the appeal on its own motion.

It is so ORDERED.

Judge’s signature:

_

/s/ Harvey Brown
 Acting individually  Acting for the Court

Date: April 4, 2017
Exhibit 32.1
 GENERAL CABLE CORPORATION
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
Pursuant To 18 U.S.C. Section 1350, As Adopted Under
Section 906 Of The Sarbanes-Oxley Act Of 2002
  1)
    
    The Report fully complies with the requirements of section
13(a) or 15(d)
of the Securities Exchange Act of 1934; and2)
    
    The information contained in the Report fairly presents, in
all material
respects, the financial condition and results of operations of the Company.
 Date: November 5, 2008
    
    /s/ GREGORY B. KENNYGregory B. KennyChief Executive OfficerDate: November 5, 2008
    
    /s/ BRIAN J. ROBINSONBrian J. RobinsonChief Financial Officer
No. 925.

No. 926.

No. 927.

#### German-American Vocational League, Inc. *v.*United States; D. A. B. Recreational Resort, Inc. *v.*United States; Schroeder *v.*United States; *834Bertram *v.*United States; Gibbe *v.*United States; Bremer *v.*United States; Koehn *v.*United States; Lieblein *v.*United States; and Schmidt *v.*United States.

No. 928.

No. 929.

No. 930.

No. 931.

No. 932.

No. 933.

April 29, 1946.

*Frederic M. P. Pearse*for petitioners.

*Solicitor General McGrath, Robert S. Erdahl*and *Beatrice Rosenberg*for the United States.

Petition for writs of certiorari to the Circuit Court of Appeals for the Third Circuit denied.
QuickLinks
 -- Click here to rapidly navigate through this document









































 Exhibit 10.14  


 CROCS, INC.  


 
    Board of Directors Compensation Plan    
    


        On June 26, 2008, the Board of Directors of Crocs, Inc. (the "Company") approved a new compensation arrangement for
non-employee directors effective as of June 26, 2008. The new compensation arrangement provides the following for non-employee directors: 



        (a)   Annual
cash compensation of $80,000 payable to each non-employee director in quarterly payments of $20,000 each; 


        (b)   Additional
annual cash compensation of $10,000 payable to the chair of the Audit Committee and additional annual cash compensation of $5,000 payable to each of the
chairs of the Governance and Nominating Committee and the Compensation Committee; 


        (c)   Annual
grant to each non-employee director of $100,000 of common stock of the Company based on the fair market value of the common stock on the date of
grant; and 


        (d)   Annual
grant to the Chairman of the Board of options to purchase 10,000 shares of common stock of the Company at an exercise price equal to the fair market value of the
common stock on the date of grant, which options will vest in four equal annual installments on the date of the annual meeting of stockholders each year. 












QuickLinks


Board of Directors Compensation Plan
Offer Letter of Kathleen J. Chappell



 Exhibit 10.9 
 OFFER LETTER OF KATHLEEN J. CHAPPELL 
 [COMPANY LETTERHEAD] 
 December 22, 2008 
 Mrs. Kathleen J. Chappell 
 109 Monet Terrace 
 Winchester, Virginia 22602 
 Dear Kate: 
 It is my pleasure to present the following offer for your employment with Bank of Clarke County and Eagle
Financial Services, Inc.: 
  

	 	•	 	 Title of Senior Vice President and Chief Financial Officer of the bank 


  

	 	•	 	 Title of Vice President and Chief Financial Officer of the holding company 


  

	 	•	 	 Annual salary of $130,000 


  

	 	•	 	 Paid-time-off in accordance with current policy 


  

	 	•	 	 Participation in the following group plans: 


  

	 	•	 	 Health insurance 


  

	 	•	 	 Life insurance 


  

	 	•	 	 Dental reimbursement 


  

	 	•	 	 Long term disability 


  

	 	•	 	 Participation in the Bank’s 401(k) Plan after 90 days of employment 


 If you agree to this offer, please sign below and return it to my attention. If you have any questions, please do not hesitate to call me. We are excited about bringing your talent and winning attitude to our
organization. 
  

	
	Sincerely,
	
	 /S/ JOHN R. MILLESON

	John R. Milleson
	President and Chief Executive Officer

 I agree to the compensation and benefits of employment offered above. 
  

					
	 /S/ KATHLEEN J. CHAPPELL
	 		 	DECEMBER 22, 2008
	SIGNATURE	 		 	DATE
EXHIBIT 99.37



                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Quarterly Report of IntegraMed America, Inc. (the
     "Company") on Form 10-Q for the period ended March 31, 2003 as filed with
     the Securities and Exchange Commission on the date hereof (the "Report"), I
     John W. Hlywak, Jr., Chief Financial Officer of the Company, certify,
     pursuant to 18 U.S.C. /s/ 1350, as adopted pursuant to section 906 of the
     Sarbanes--Oxley Act of 2002, that:

        1.    The Report fully complies with the  requirements  of Section 13(a)
              or 15(d) of the Securities Exchange Act of 1934; and

        2.    The information  contained in the Report fairly  presents,  in all
              material  respects,   the  financial   condition  and  results  of
              operations of the Company.



                                           /s/John W. Hlywak, Jr.
                                              ------------------------
                                              John W. Hlywak, Jr.
                                              Chief Financial Officer
                                              May 15, 2003



     Note: A signed original of this written  statement  required by Section 906
     has been  provided  to  IntegraMed  America,  Inc.  and will be retained by
     IntegraMed  America,  Inc.  and  furnished to the  Securities  and Exchange
     Commission or its staff upon request.
Exhibit 32.4

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(b) OF THE EXCHANGE ACT AND 18 U.S.C. SECTION 1350.

In connection with the Annual
Report on Form 10-K of Curis, Inc. (the Company) for the fiscal year ended December 31, 2008, as amended by Amendment No. 1 filed with the Securities and Exchange Commission on the date hereof (as amended, the
Report), the undersigned, Michael P. Gray, Vice President of Finance and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.

Dated: November 13, 2009



|                                                   
|---------------------------------------------------
|/S/ MICHAEL P. GRAY                                
|Michael P. Gray                                    
|Chief Operating Officer and Chief Financial Officer
|(Principal Financial and Accounting Officer)
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket Nos. FDA-2013-E-0264; FDA-2013-E-0263; and FDA-2013-E-0218]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notification of affirmation.

# DATES:

August 23, 2017

# FOR FURTHER INFORMATION CONTACT:

Joyce Strong, Office of Policy, 10903 New Hampshire Ave., Bldg. 51, Silver Spring, MD 20993, 301-796-9148.

# SUPPLEMENTARY INFORMATION:

                    The Food and Drug Administration (FDA) is affirming the signature date for a notice that appeared in the                     **Federal Register**                     on August 21, 2017 (82 FR 39587). The document announced FDA's determination for the regulatory review period for RECUVYRA. The document published with an incorrect date for the signature. We affirm that the document was signed on August 15, 2017.                

Dated: August 21, 2017.

Leslie Kux,

Associate Commissioner for Policy.

[FR Doc. 2017-17961 Filed 8-21-17; 4:15 pm]

BILLING CODE 4164-01-P
# download_1999_nat_estimates_spr
**Exhibit 32.1**

 

**CERTIFICATIONPursuant to 18 United States Code Section 1350,As adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002**

 

The undersigned hereby certifies that, to myknowledge, the Quarterly Report on Form 10-Q for the period ended September 30,2005 of Graphic Packaging Corporation (the “Company”) filed with the Securitiesand Exchange Commission on the date hereof fully complies with the requirementsof section 13(a) or 15(d) of the Securities Exchange Act of 1934and that the information contained in such report fairly presents, in allmaterial respects, the financial condition and results of operations of theCompany.

 

 
|   | /s/ STEPHEN M. HUMPHREY                      |
|--------|----------------------------------------------|
|   | Name: Stephen M. Humphrey                    |
|   | Title: President and Chief Executive Officer |
|   | November 3,  2005                       |

 

----